- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07720661
Comparative Outcomes of Mammary Artery Harvesting: Infection, Occlusion Rates and Thoracic Pain Assessment (COMFORT)
COMFORT: Comparative Outcomes of Mammary Artery Harvesting: Infection, Occlusion Rates and Thoracic Pain Assessment
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
The COMFORT trial is an international, multicentre, blinded, expertise-based randomized controlled trial evaluating two commonly used techniques for harvesting the left internal mammary artery (LIMA) during coronary artery bypass grafting (CABG): skeletonized and non-skeletonized (pedicled) harvesting.
Although skeletonized harvesting has been associated with reduced sternal wound complications and postoperative pain, concerns have emerged regarding its potential impact on graft patency and long-term cardiovascular outcomes. Existing evidence is largely derived from observational studies and post hoc analyses, and no adequately powered randomized trial has prospectively compared these techniques using systematic imaging-based graft assessment.
The COMFORT trial will enroll approximately 1,116 patients undergoing isolated CABG with a planned LIMA-to-LAD graft. Participants will be randomly assigned to undergo either skeletonized or non-skeletonized LIMA harvesting performed by surgeons experienced in both techniques. Participants and outcome assessors will remain blinded to treatment allocation.
Participants will undergo protocol-mandated coronary computed tomography angiography (CTA) at 1.5 years after surgery, with follow-up extending to 2 years. Independent blinded committees and a central CTA core laboratory will adjudicate imaging and clinical outcomes. In addition to graft assessment, the study will evaluate the effects of harvesting technique on cardiovascular outcomes, sternal wound complications, chronic postoperative pain, quality of life, and healthcare resource utilization.
The findings of COMFORT are expected to provide definitive evidence to guide surgical practice and inform future guidelines regarding the optimal method of internal mammary artery harvesting during CABG surgery.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Ingrid Copland
- Telefonnummer: 905-296-5754
- E-Mail: comfort@phri.ca
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Age 18 years or older
- Undergoing isolated CABG surgery with median sternotomy and a planned LIMA-LAD graft
- Provision of written informed consent
Exclusion Criteria:
- Non-sternotomy surgical approach (e.g., minimally invasive, thoracotomy)
- Emergency surgery (defined as surgery required within 24 hours of presentation)
- History of prior sternotomy
- Currently receiving systemic antibiotics or with an active bacterial infection at the time of surgery
- History of chronic sternal pain prior to the index surgery
- Known left subclavian artery stenosis (>50%)
- Previous radiation therapy to the chest
- Known allergy or contraindication to iodinated contrast media that cannot be managed with premedication
- Estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m² at baseline (relative contraindication to CTA contrast) as determined based on each centre's laboratory standard.
- Known pregnancy or plans for pregnancy during the study period
- Life expectancy less than 1.5 years due to non-cardiac conditions
- Inability or unwillingness to comply with follow-up procedures including CTA at 1.5 years
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Vervierfachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Skeletonized LIMA Harvesting
Harvesting of the left internal mammary artery as a skeletonized conduit during CABG surgery, with removal of surrounding tissues while preserving the artery as an isolated graft conduit.
|
Skeletonized (SK) harvesting of the left internal mammary artery (LIMA) to left anterior descending artery (LAD) graft: the LIMA is isolated without surrounding satellite veins, endothoracic fascia, and intercostal nerves
|
|
Aktiver Komparator: Non-Skeletonized LIMA Harvesting
Conventional pedicled harvesting of the left internal mammary artery during CABG surgery, with preservation of the surrounding veins, fascia, and supporting tissues around the graft conduit.
|
Non-skeletonized (non-SK) harvesting of the LIMA-LAD graft: the LIMA is harvested with surrounding satellite veins, endothoracic fascia, and intercostal nerves (standard pedicled technique)
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Graft Patency
Zeitfenster: 1.5 years after surgery
|
Binary assessment of LIMA-LAD graft patency versus graft failure
|
1.5 years after surgery
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
MACE
Zeitfenster: 2 years after surgery
|
The composite of cardiovascular mortality, myocardial infarction, or repeat revascularization
|
2 years after surgery
|
|
Sternal Surgical Site Infection
Zeitfenster: 90 days after surgery
|
The composite of sternal surgical site infection
|
90 days after surgery
|
|
Sternal Chronic Postsurgical Pain
Zeitfenster: 90 days after surgery
|
The composite of non-infected sternal chronic postsurgical pain
|
90 days after surgery
|
|
LIMA-LAD Driven Repeat Revascularization or Occlusion
Zeitfenster: 2 years after surgery
|
Any coronary revascularization procedure (PCI or CABG) targeting the LIMA-LAD graft territory, or occlusion of the LIMA-LAD graft revealed by clinically indicated coronary angiography or CTA
|
2 years after surgery
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Andre Lamy, MD, Population Health Research Institute
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Postoperative Komplikationen
- Pathologische Prozesse
- Herzkrankheiten
- Infektionen
- Arteriosklerose
- Arterielle Verschlusskrankheiten
- Koronare Krankheit
- Myokardischämie
- Wundinfektion
- Pathologische Zustände, Anzeichen und Symptome
- Koronare Herzkrankheit
- Chirurgische Wundinfektion
Andere Studien-ID-Nummern
- COMFORT
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Koronare Herzkrankheit
-
Zhejiang Cancer HospitalRekrutierungHepatic Artery Infusion | Lebermetastasen bei BrustkrebsChina
-
National Medical Research Center for Therapy and...Stupino Clinical Hospital, Moscow Region State Medical InstitutionAbgeschlossenUNTERSCHALTE CORONARY SYNDROMERussland
-
Medical University of WarsawRekrutierungANOCA | Angina ohne obstruktive Koronararterienerkrankung | Coronary Sinus ReduderPolen
Klinische Studien zur Skeletonized LIMA Harvesting
-
Jagiellonian UniversityAbgeschlossenKoronare Herzkrankheit | Koronararterien-Bypass | Blutverlust, postoperativ | Interne Mamma-Koronararterien-Anastomose | FibrinolysePolen
-
Centre Hospitalier Universitaire, AmiensRekrutierungChirurgie | KnochenschwundFrankreich
-
Indonesia UniversityAbgeschlossenGaumenspalte | Fistel des weichen Gaumens (Erkrankung) | OberkieferhypoplasieIndonesien
-
Beijing Anzhen HospitalUnbekanntKoronare atherosklerotische HerzkrankheitChina
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR)Abgeschlossen
-
Assiut UniversityNoch keine RekrutierungLAD (Left Anterior Descending) Koronararterienstenose
-
Emilia BagiellaNational Heart, Lung, and Blood Institute (NHLBI)Abgeschlossen
-
Ettore Sansavini Health Science FoundationBeendetKoronare Herzkrankheit (KHK)Italien
-
Rigshospitalet, DenmarkLundbeck Foundation; Danish Heart Foundation; Copenhagen Hospital CorporationUnbekanntAngina pectoris | Ischämische Herzerkrankung | Koronare ArterioskleroseDänemark
-
Yuzuncu Yıl UniversityAbgeschlossen